Exchange: NASDAQ·Updated 04:35 PM EST
DFTX logo

DFTX Definium Therapeutics Inc.

$28.09
$1.14
(3.87%)
Today
Closed $28.34
$0.2504
(0.88%)
After Hours
Reported EarningsNov 9
Mkt Cap$4.04B
Vol3.23M

About DFTX

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
32

Bearish Sentiment

How do you feel about DFTX?

MichaelNaussCMT
$DFTX funny, they do this when you’re likely only a couple weeks out from pre nda meeting.
10
MichaelNaussCMT
$DFTX they completely destroyed earnings, losing way less money than was expected for a biotech their side and doing their research. However, that’s generally not what moves biotechs. We’re still just waiting for NDA, which they have reiterated, will be in by the end of the year, so we’ve got maybe another six weeks. 
10
bill791
$DFTX Mabey it's already been mentioned but it sounds like Fidelity just took a Megalodon size bite of the company ...discuss
7
a_rational_investor
$DFTX I don't pretend to be an expert on analyzing stock charts but to me it seems as if we're on a ride back up to new 52W highs.
7
MichaelNaussCMT
$DFTX bob Moore today seems we holding that lower trend line well, so I should use the opportunity to buy some scallop out when we’re back above 50
5
brunoq14
$DFTX Perhaps they're saving an announcement of the pre-NDA meeting with the FDA for earnings. But it's kind of ridiculous, because with BTD you can communicate with the FDA all the time.
1
1
shoc24
$DFTX reported earnings after the close today. GAAP EPS beat estimates: -$0.46 vs. -$0.56 expected, according to Stock Meadow.
3
StocktwitsEarnings
$DFTX Q3 '26 Earnings Results & Recap Definium Therapeutics reported Q3 2026 research and development expenses of $46.1M and general and administrative expenses of $26.1M; net loss was $51M, or $0.37 basic per share.
3
FBP
$DFTX Nov 9th Monday earnings AH confirmed. Flag at bottom just waiting for the pivot point decision which imo happens no later than next week.
3
investpapaya
$DFTX Dissapointing price action today. I would like to hear people's perspectives. My understanding - it is derisking, profit taking, and bearish technical trend. Am i missing anything? What level of "dip" are are you accumulating?
2
regimecard
$DFTX Regime check: the US market closed at 14.0, MILDLY OFF, on Nov 13. How DFTX has done in MILDLY OFF markets: a typical 3-month return of -24.4%, history only. With the US market still reading MILDLY OFF at the close, the question for a therapeutics name like DFTX is how its corner of the market sits while risk appetite holds in this regime.
1
Merlintrader
Definium $DFTX will present at a string of investor conferences. Stifel Nov 10 (9:20 a.m. ET), Jefferies Nov 17 and 19, Evercore and Piper Sandler Dec 1-2. Shares closed at $32.47 on Monday, below the SMA50 and above the SMA200, RSI 37. More details in our hub. Not investment advice.
1
Roaring_Capybara
$DFTX Off Topic - MIRA on sale !!! Do some due diligence - They have "Ketamir-2" in their pipeline that could have incredible potential as a NON-controlled substance to treat pain, depression, and anxiety. Ketamir-2 is designed to be similar to ketamine ..... without the negative effects....
flabb
$DFTX 29.72 took a position (new soldier) will add if she falls. Keep on Building your Army !! Battle On !
leLu83
$DFTX cherry has broke and 24s are on deck. Hope raising a billion on shareholders was worth it retail 🙏 🙌

Advertisement|Remove ads.